188 related articles for article (PubMed ID: 32488412)
21. Utility of MUC4 in the diagnosis of secretory carcinoma of salivary glands.
Fatima S; Ahmed A; Suleman S; Din NU
Ann Diagn Pathol; 2023 Dec; 67():152220. PubMed ID: 37924657
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Approaches for Salivary Gland Tumors with Secretory and Microcystic Features.
Woo HY; Choi EC; Yoon SO
Head Neck Pathol; 2018 Jun; 12(2):237-243. PubMed ID: 29139086
[TBL] [Abstract][Full Text] [Related]
23. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
Su YJ; Lee YH; Jin YT; Hsieh MS
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):264-272. PubMed ID: 35384876
[TBL] [Abstract][Full Text] [Related]
24. Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis.
Osako T; Takeuchi K; Horii R; Iwase T; Akiyama F
Histopathology; 2013 Oct; 63(4):509-19. PubMed ID: 23944930
[TBL] [Abstract][Full Text] [Related]
25. Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland.
Hsieh MS; Chou YH; Yeh SJ; Chang YL
Virchows Arch; 2015 Aug; 467(2):145-53. PubMed ID: 25976476
[TBL] [Abstract][Full Text] [Related]
26. Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System.
Baněčková M; Thompson LDR; Hyrcza MD; Vaněček T; Agaimy A; Laco J; Simpson RHW; Di Palma S; Stevens TM; Brcic L; Etebarian A; Dimnik K; Majewska H; Stárek I; O'Regan E; Salviato T; Helliwell T; Horáková M; Biernat W; Onyuma T; Michal M; Leivo I; Skalova A
Am J Surg Pathol; 2023 Jun; 47(6):661-677. PubMed ID: 37070739
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.
Suzuki K; Harada H; Takeda M; Ohe C; Uemura Y; Kawahara A; Sawada S; Kanda A; Sengupta B; Iwai H
BMC Med Genomics; 2022 Jan; 15(1):6. PubMed ID: 34991563
[TBL] [Abstract][Full Text] [Related]
28. The screening and electron microscopy observation of mammary analogue secretory carcinoma in Chinese.
Zhong Y; Liu L; Qi B; Song X; Shen L; Li H
J Craniomaxillofac Surg; 2018 Jun; 46(6):893-897. PubMed ID: 29752049
[TBL] [Abstract][Full Text] [Related]
29. A case of "ETV6-FISH-negative" secretory carcinoma of the parotid gland: immunohistochemical study.
Harada H; Irie K; Nakatsuka SI; Sasaguri T; Honma K; Kurose A
Med Mol Morphol; 2021 Sep; 54(3):296-300. PubMed ID: 33452913
[TBL] [Abstract][Full Text] [Related]
30. Cytopathological features of mammary analogue secretory carcinoma--review of literature.
Takeda M; Kasai T; Morita K; Takeuchi M; Nishikawa T; Yamashita A; Mikami S; Hosoi H; Ohbayashi C
Diagn Cytopathol; 2015 Feb; 43(2):131-7. PubMed ID: 24652816
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic accuracy of pan-TRK immunohistochemistry in differentiating secretory carcinoma from acinic cell carcinoma of salivary gland-A systematic review.
Sharma P; Sivakumar N; Pandiar D
J Oral Pathol Med; 2023 Mar; 52(3):255-262. PubMed ID: 36207812
[TBL] [Abstract][Full Text] [Related]
32. Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.
Xu B; Haroon Al Rasheed MR; Antonescu CR; Alex D; Frosina D; Ghossein R; Jungbluth AA; Katabi N
Histopathology; 2020 Feb; 76(3):375-382. PubMed ID: 31448442
[TBL] [Abstract][Full Text] [Related]
33. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
Drilon A; Li G; Dogan S; Gounder M; Shen R; Arcila M; Wang L; Hyman DM; Hechtman J; Wei G; Cam NR; Christiansen J; Luo D; Maneval EC; Bauer T; Patel M; Liu SV; Ou SH; Farago A; Shaw A; Shoemaker RF; Lim J; Hornby Z; Multani P; Ladanyi M; Berger M; Katabi N; Ghossein R; Ho AL
Ann Oncol; 2016 May; 27(5):920-6. PubMed ID: 26884591
[TBL] [Abstract][Full Text] [Related]
34. Cytopathologic features of mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista DA; Westra WH; Ali SZ
Cancer Cytopathol; 2013 May; 121(5):228-33. PubMed ID: 23042752
[TBL] [Abstract][Full Text] [Related]
35. Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
Del Castillo M; Chibon F; Arnould L; Croce S; Ribeiro A; Perot G; Hostein I; Geha S; Bozon C; Garnier A; Lae M; Vincent-Salomon A; MacGrogan G
Am J Surg Pathol; 2015 Nov; 39(11):1458-67. PubMed ID: 26291510
[TBL] [Abstract][Full Text] [Related]
36. [Mammary analog secretory carcinoma of the parotid gland].
Guérin M; Diedhiou A; Nallet E; Duflo S; Laé M; Wassef M
Ann Pathol; 2014 Oct; 34(5):384-7. PubMed ID: 25439992
[TBL] [Abstract][Full Text] [Related]
37. Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.
Mariano FV; Gómez CA; de Souza do Nascimento J; Dos Santos HT; Egal ES; Montalli VA; Vargas PA; de Almeida OP; Altemani A
Head Neck Pathol; 2016 Dec; 10(4):429-436. PubMed ID: 27177644
[TBL] [Abstract][Full Text] [Related]
38. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
[TBL] [Abstract][Full Text] [Related]
39. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H
Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
[TBL] [Abstract][Full Text] [Related]
40. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
